The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
10,876
Sort by:
Vitamin D Testing Market Analysis By Type of Test (25-Hydroxy Vitamin D Tests; 1, 25-Dihydroxy Vitamin D Tests), Region (North America, Europe, Asia Pacific, South & Central America, MEA), And Segment Forecasts, 2014 - 2025
US$ 5,950.00
The global vitamin D testing market is expected to reach USD 1.1 billion by 2025, according to a new report by ... level of vitamin D in two forms. Hence, the market has been divided by two major types of tests, namely 25-Hydroxy Vitamin D test and 1, 25-Dihydroxy vitamin test. The 5-hydroxy vitamin D tests or ...
May 2017
100 pages
Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)
US$ 2,000.00
... backing the growth of Global Influenza Market. According to Azoth Analytics research report, “Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis ...
May 2017
164 pages
Drug Testing: Technologies and Global Markets
US$ 2,500.00
The global drug of abuse (DOA) testing market reached nearly $3.0 billion in 2016. This market is estimated to grow at a compound annual growth rate ( ... 2022 from $3.1 billion in 2017. Urine DOA testing, the largest segment of the market, reached $1.7 billion in 2016. This market is estimated to grow at a CAGR ...
May 2017
135 pages
Global Head Lice Infestation Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022
US$ 3,480.00
... is head to head contact. Lice are human parasites that feed on the blood of the infested person. SCOPE OF THE REPORT: This report focuses on the Head Lice Infestation Drug in Global market ... Adult There are 15 Chapters to deeply display the global Head Lice Infestation Drug market. Chapter 1, to describe Head Lice Infestation Drug Introduction, product scope, market overview, market opportunities, market ...
May 2017
117 pages
North America Dental Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022
US$ 4,480.00
... North America Dental Drug market. Chapter 1, to describe Dental Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Dental Drug ...
May 2017
121 pages
North America Probiotics Market by Manufacturers, Countries, Type and Application, Forecast to 2022
US$ 4,480.00
... Other Market Segment by Applications, can be divided into Food & Beverage Drugs Dietary Supplements Others There are 15 Chapters to deeply display the North America Probiotics market. Chapter 1, to describe Probiotics Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Probiotics ...
May 2017
117 pages
Global Dental Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022
US$ 3,480.00
... Hospitals Dental Clinics Drugstores There are 15 Chapters to deeply display the global Dental Drug market. Chapter 1, to describe Dental Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Dental Drug, with ...
May 2017
121 pages
Global Duchenne Muscular Dystrophy Therapeutics Market By Drug (Translarna, Emflaza, EXONDYS 51), By Therapeutic Approach (Steroid Therapy, Exon Skipping, Mutation Suppression) Clinical Trial Assessment & Pipeline Analysis (By Phase, Geography, and Key Player) Outlook 2022
US$ 2,500.00
... market. According to RNCOS’ new research report “Global Duchenne Muscular Dystrophy Therapeutics Market By Drug (Translarna, Emflaza, EXONDYS 51), By Therapeutic Approach (Steroid Therapy, Exon Skipping, Mutation Suppression ... position of Europe in the Duchenne Muscular Dystrophy market. The later part of the report discusses some of the prominent players in the global Duchenne Muscular Dystrophy Therapeutics market. The market ...
May 2017
100 pages
Global Hemophilia Therapeutics Market By Drug (Advate, NovoSeven, Kogenate/Kovaltry, Feiba), By Type of Hemophilia (Hemophilia A, Hemophilia B), By Treatment (On-Demand, Prophylaxis), By Therapy (Replacement Therapy, Immune Tolerance Induction Therapy) Outlook 2022
US$ 2,500.00
... growth of the global hemophilia therapeutics market. The global hemophilia therapeutics market has been segmented on the basis of type of hemophilia, i.e. Hemophilia A, Hemophilia B, and Others. Hemophilia A occupies the largest share in the global hemophilia therapeutics market, owing to the ...
May 2017
95 pages
Global Peptide Therapeutics Market & Clinical Trials Insight 2022
US$ 3,000.00
... Therapeutics Peptide Therapeutics by Applications & Indications Peptides Clinical Trials Insight by Phase, Indication & Company Insight on 688 Peptide Drugs in Clinical Trials Clinical & Patent Insight on 119 Marketed Peptides Future Peptide Therapeutics Market Outlook “Global Peptide Therapeutics Market ...
May 2017
1300 pages
Global Intravenous (IV) Iron Drugs Market: Industry Analysis & Outlook (2017-2021)
US$ 800.00
... body. The report “Global I.V. Iron Drugs Market” provides a comprehensive study of iron product market and I.V. iron market globally. It also provides ... industry are paradigm shift from oral iron drugs to intravenous iron drugs and introduction of first generation drugs InFeD and Dexeferrum. However, the ...
April 2017
64 pages
ASIA PACIFIC DRUG DISCOVERY MARKET FORECAST 2017-2024
US$ 1,950.00
... , Australia and rest of Asia Pacific. The entry of new companies in the market and substitute products acts as a threat to the Asia pacific drug discovery market. Discovery of new drugs being delayed due ...
April 2017
61 pages
EUROPE DRUG DISCOVERY MARKET FORECAST 2017-2024
US$ 1,950.00
... Europe drug discovery market are UK, France, Germany, Spain, Italy and rest of Europe. The entry of new companies in the market and substitute products poses a threat to the Europe drug discovery market. Discovery ...
April 2017
67 pages
Global Double Barreled Antibodies Drug Sales (BLINCYTO & Removab), Pipeline Analysis (By Phase, Technology, and Indication), & Global Market Forecasts 2022
US$ 2,500.00
... resulting bi-specific antibody has binding affinities for two or three different epitopes concomitantly. According to the RNCOS report entitled “Global Double Barreled Antibodies Drug Sales (BLINCYTO & Removab), Pipeline Analysis (By Phase, Technology, and Indication), & Global Market Forecasts 2022”, the double barreled antibodies market is anticipated ...
April 2017
80 pages
Global Hepatocellular Carcinoma Drug Sales (Nexavar & Miripla), Pipeline Analysis and Global Market Forecast 2022
US$ 2,500.00
... , or NASH. As per RNCOS report “Global Hepatocellular Carcinoma Drug Sales (Nexavar & Miripla), Pipeline Analysis and Global Market Forecast 2022” the global hepatocellular carcinoma drug market is anticipated to witness a remarkable growth ... acquisitions taking place in the global hepatocellular carcinoma drug market. The last section of the report discusses about the prominent players in global hepatocellular carcinoma drug market. A brief business ...
April 2017
70 pages
GLOBAL PROBIOTICS MARKET FORECAST 2017-2025
US$ 2,500.00
... The Probiotic market size is projected to grow from $37741 million in 2016 to $71948 million by 2025. The market is anticipated to grow at a CAGR of 7.49% during the forecast period of 2017-2025. The ...
April 2017
136 pages
Generic Drugs Market in India 2017
US$ 950.00
... placed. Netscribes’ latest market research report titled Generic Drugs Market in India 2017 covers the current and future state of the generics market in the country. ... are removed. COVERAGE: Overview of the generics drugs market in India, and historical and forecasted market size data over 2012 to 2020 Trade ...
April 2017
64 pages
Charting the Orphan Drug Development Pipeline
US$ 695.00
... /developers are setting the pace? Charting the Orphan Drug Development Pipeline analyses 3,868 unique molecules from 2,257 developers to create the most comprehensive independent analysis of orphan drug ... Overview Orphan drug market dynamics Legal definitions and incentives for orphan drug development in US and EU Trends in orphan drug designation For each therapy area covered EU/US designated drugs Orphan drugs designated ...
April 2017
-
Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022) - By Region (N. America, Europe, APAC, RoW); By Country (US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa)
US$ 1,800.00
... antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs. According to Azoth Analytics research report, “Global Antibody Drug Conjugates (ADC ...
March 2017
154 pages
2017 U.S. Drugs of Abuse POC/Point-of-Care Testing Market: Physician Offices, Emergency Rooms, Ambulatory Care Centers-- Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 2,250.00
... VPGMarketResearch contains 14 tables, and provides a comprehensive analysis of the POC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements ... sales forecasts for drugs of abuse procedures by market segment: Physician Offices/Group Practices Emergency Rooms Ambulatory Care Centers Analysis of drugs of abuse procedures Competitive ...
March 2017
165 pages
GLOBAL DRUG DISCOVERY MARKET FORECAST 2017-2024
US$ 2,500.00
... accounts for the second largest market in the global drug discovery market. Asia-Pacific market is projected to grow during the forecast period due to increase in the number of contract ...
March 2017
187 pages
2017 Shimadzu: Challenges, Technological Capabilities, Marketing Tactics, Strategic Direction in the Global Medical Imaging Industry
US$ 2,475.00
... new report from VPGMarketResearch provides insightful analysis of Shimadzu capabilities, goals and strategies in the global diagnostic imaging market. ... ultrasound, MRI, CT, nuclear medicine, PET, PACS and other technologies. The analysis of Shimadzu includes: Business, new product development, and marketing ...
March 2017
40 pages
2017 Europe Drugs of Abuse Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 5,850.00
... -page report from VPGMarketResearch provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... , Phencyclidine (PCP), Propoxphene.During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...
March 2017
300 pages
Infectious Disease Drugs: The Chinese Market
US$ 5,500.00
This infectious disease drugs report by BCC Research analyzes infectious disease market applications, industry structure, and marketing and distribution.
March 2017
164 pages
Global Rheumatoid Arthritis Drug Market Outlook 2022
US$ 1,500.00
... Mechanism of Rheumatoid Arthritis Drugs Synthetic DMARDs as Rheumatoid Arthritis Drug Biological Agents as Rheumatoid Arthritis Drug Global Market of Rheumatoid Arthritis Drug Global Tendencies in Use of Antirheumatics Global Rheumatoid Arthritis Drug Market ...
March 2017
90 pages
US Antidiabetics Drug Market Outlook 2022
US$ 1,800.00
... market revenue was generated by Lantus, which is marketed by Sanofi. “US Antidiabetics Drug Market Outlook 2022” report highlights: US Diabetes Epidemiology US Antidiabetics Market Overview Key Marketed Antidiabetic Drugs in US US Biosimilar Insulin Market US Antidiabetics Drug Market ...
March 2017
120 pages
Orphan Drug - Global Market Outlook (2016-2022)
US$ 4,150.00
According to Stratistics MRC, the Global Orphan Drug market is estimated at $145.89 million in 2016 and is expected to reach $265.63 million by ... pharmaceutical companies on orphan drug improvement, increasing occurrence of rare diseases, government incentives for orphan medicine are some factors favouring the market growth. However ...
March 2017
148 pages
Global Ophthalmic Drugs Market Analysis & Forecast Report 2017-2022
US$ 2,600.00
The Global Ophthalmic Drugs Market Analysis & Forecast Report 2017-2022 is a professional and in-depth study on the current state of the Ophthalmic Drugs Market. The report analysis the global market of Ophthalmic Drugs by main manufactures and geographic regions. The report includes Ophthalmic Drugs definitions, classifications, applications and ...
February 2017
105 pages
Global Antibody Drug Conjugates Market By Drug (ADCETRIS, Kadcyla), Pipeline Analysis (By Phase, Mode of Action, Linker, Technology, and Indication) Outlook 2022
US$ 2,000.00
... by several Antibody Drug Conjugates (ADCs) in pipeline highlight the potential for new therapeutic innovations in this industry. According to the RNCOS report entitled “Global Antibody Drug Conjugates Market By Drug (ADCETRIS, Kadcyla), Pipeline Analysis (By Phase, Mode of Action, Linker, Technology, and Indication) Outlook 2022”, the ADC market is poised ...
February 2017
120 pages
Global Psoriasis Drugs Market by Drug Molecule (Biologic, Small Molecule Drugs), By Route of Administration (Systemic, Topical), By Mechanism of Action (TNF Inhibitors, Interleukin Blockers) Outlook 2022
US$ 2,500.00
... “Global Psoriasis Drugs Market by Drug Molecule (Biologic, Small Molecule Drugs), By Route of Administration (Systemic, Topical), By Mechanism of Action (TNF Inhibitors, Interleukin Blockers) Outlook 2022”, the global psoriasis drugs market is anticipated ... growth of the global psoriasis drugs market. The global psoriasis drugs market has been segmented on the basis of type of drug molecule into biologics drugs and small molecule/chemical drugs. Biologics are ...
February 2017
70 pages
